IT1391251B1 - COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES - Google Patents
COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASESInfo
- Publication number
- IT1391251B1 IT1391251B1 ITMI2008A001829A ITMI20081829A IT1391251B1 IT 1391251 B1 IT1391251 B1 IT 1391251B1 IT MI2008A001829 A ITMI2008A001829 A IT MI2008A001829A IT MI20081829 A ITMI20081829 A IT MI20081829A IT 1391251 B1 IT1391251 B1 IT 1391251B1
- Authority
- IT
- Italy
- Prior art keywords
- treatment
- composition
- articular diseases
- articular
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/505—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2008A001829A IT1391251B1 (en) | 2008-10-15 | 2008-10-15 | COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2008A001829A IT1391251B1 (en) | 2008-10-15 | 2008-10-15 | COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20081829A1 ITMI20081829A1 (en) | 2010-04-16 |
IT1391251B1 true IT1391251B1 (en) | 2011-12-01 |
Family
ID=40636695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2008A001829A IT1391251B1 (en) | 2008-10-15 | 2008-10-15 | COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1391251B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201700110784A1 (en) * | 2017-10-03 | 2019-04-03 | Fidia Farm Spa | Pharmaceutical compositions containing Hyaluronic acid and Carnosine and its use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61186322A (en) * | 1985-02-13 | 1986-08-20 | Nippon Univ | Immunomodulator |
IT1281876B1 (en) * | 1995-05-10 | 1998-03-03 | Fidia Advanced Biopolymers Srl | HYALURONIC ACID AND ITS ESTER DERIVATIVES FOR THE PREPARATION OF MATRIXES FOR THE CONTROLLED RELEASE OF DRUGS. |
DE10111165A1 (en) * | 2001-03-02 | 2002-10-10 | Knoell Hans Forschung Ev | Use of hyaluronic acid uronides for the treatment of inflammatory processes |
DE10246340A1 (en) * | 2002-10-04 | 2004-04-29 | Wohlrab, David, Dr. | Combination preparation of hyaluronic acid and at least one local anesthetic and its use |
-
2008
- 2008-10-15 IT ITMI2008A001829A patent/IT1391251B1/en active
Also Published As
Publication number | Publication date |
---|---|
ITMI20081829A1 (en) | 2010-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2020032I2 (en) | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES CAUSED BY MICROBES | |
BRPI1012116A2 (en) | pharmaceutical composition for the treatment of heart disease | |
BRPI0908026A2 (en) | Methods for the treatment of bowel diseases | |
SMAP200900085A (en) | 3-imidazolyl-indoles for the treatment of malolysiseproliferative | |
SMT201600055B (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF GLAUCOMA | |
DK2504005T3 (en) | USE OF 1,3-DIPHENYLPROP-2-ONE-1-DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES | |
IL200368A0 (en) | Treatment of diseases characterized by inflammation | |
IL208357A0 (en) | Spiro-indole derivatives for the treatment of parasitic diseases | |
IT1391866B1 (en) | INJECTIONABLE COMPOSITION OF POLYNUCLEOTIDS FOR THE TREATMENT OF OSTEOARTICULAR DISEASES. | |
HK1141447A1 (en) | Pharmaceutical composition for the treatment of proliferative diseases | |
BR112012004836A2 (en) | pyrazinylpyridines useful for the treatment of proliferative diseases | |
IL211313A0 (en) | Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies | |
DK2117565T3 (en) | APPLICATION OF CHITOSANES FOR THE TREATMENT OF NON-FLAMMATORY DISEASES | |
ITRM20050179A1 (en) | APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES. | |
ZA201009072B (en) | Pharmaceutical composition for the treatment of premature ejaculation | |
BRPI0914454A2 (en) | "composition for the treatment of epithelial tissue" | |
ZA200905364B (en) | Treatment of diseases characterized by inflammation | |
BRPI0914139A2 (en) | Pediatric compositions for the treatment of multiple sclerosis | |
IT1397838B1 (en) | COMPOSITION FOR TREATMENT OF PLANTS | |
BRPI0915761A2 (en) | heterocyclyl compound for treatment of cardiovascular disease | |
BRPI0912679A2 (en) | pharmaceutical composition for the treatment of fibromyalgia | |
HK1158954A1 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases | |
PL2323625T3 (en) | New composition for the treatment of ecchymotic pigmentations | |
IL200753A (en) | Pharmaceutical composition comprising ib-meca for the treatment of psoriasis | |
SMT201300156B (en) | Sulfonamide compounds for the treatment of respiratory disorders |